Strong Market Performance and Growth Potential of Furoscics Propels scPharmaceuticals to a ‘Buy’ Rating

Cantor Fitzgerald Remains a Buy on Vertex Pharmaceuticals (VRTX)

Challenges and Opportunities for Japan in 2024

Vital Energy Inc. Announces New $10 Million Credit Facility

Trading Crude Oil: Navigating OPEC’s Pricing Power